WiCON | Pharma China (Web Edition)

ONLINE ENQUIRY

WiCON International Group
Bellevue, WA 98007, USA
info@pharmachinaonline.com

WiCON International Co. Ltd.
Osaka, Japan
info@pharmachinaonline.com

China Releases Updated NRDL and First Commercial Insurance Innovative Drug Lis... China announced on December 7 the release of an updated National Reimbursement Drug List (NRDL) and the country's first Commercial Insurance Innovative Drug List, marking...
(12/8/2025)

China Biotech Dealmaking and Financing Stay St... (2/13/2026)

China NMPA Approves Nine New Drugs in January ... (2/12/2026)

Today's China Crucible: What It Means for Phar... (2/12/2026)

China Overhauls Drug Administration Rules, Emp... (2/10/2026)

China Biotech Lights Up. U.S. Stocks Prepare F... (2/10/2026)

Global Pharma in 2025: China Remains a Key Mar... (2/5/2026)

China Biotech Emerges as Global Deal Powerhous... (2/5/2026)

China's Innovation in Translational Medicine: ... (1/29/2026)

China's Labs Pull Ahead as Global Drugmakers I... (1/27/2026)

China's Early-Stage Drug Advantage Seen Persis... (1/27/2026)

China's Commercial Health Insurance Payouts fo... (1/23/2026)

China Emerges as Credible Challenger to US in ... (1/21/2026)

Recordati to Withdraw from China After R... (2/14/2026) Shenzhen Immunofoco Biotechnology files ... (2/13/2026) ProteLight Pharmaceuticals Files Hong Ko... (2/13/2026) VivaVision Files Hong Kong IPO to Fund L... (2/13/2026) Salubris Files Hong Kong IPO to Expand C... (2/13/2026) Pentagon Reverses Decision After Briefly... (2/13/2026) Gilead Acquires Global Rights to Genhous... (2/13/2026) CDE Issues Draft Pharmaceutical Guidance... (2/12/2026) Ascletis Picks Oral Amylin Agonist ASC36... (2/12/2026) RemeGen Advances PD-1/VEGF BsAb RC148 In... (2/12/2026) Lilly's Jaypirca Approved in China for P... (2/12/2026) Lilly China's Mounjaro Approved for Type... (2/12/2026) UniXell Raises Over CNY 50M in Series A+... (2/12/2026) China Indicts AstraZeneca and Former Chi... (2/12/2026) China Issues Revised Rules for National ... (2/11/2026) Eli Lilly's Omvoh Approved in China for ... (2/11/2026) Betta Pharma Wins China Approval for Per... (2/11/2026) Regend Raises CNY 350M Series C to Advan... (2/11/2026)

China's Vaccine Exports Jump More Than 50% in 2025 as O... China's Vaccine Market Set for Slow but Steady Growth T... China Companion Animal Health Market to Reach US$ 3.7B ... China's Pet Obesity Sparks Biotech Race for Weight-Loss... China's Human Vaccine Market Set for Steady Long-Term E...

Recordati to Withdraw from China After Rare Disease Por... Gilead Acquires Global Rights to Genhouse Oral Cancer D... Salubris Files Hong Kong IPO to Expand Cardiovascular-K... VivaVision Files Hong Kong IPO to Fund Late-Stage Ophth... ProteLight Pharmaceuticals Files Hong Kong IPO applicat...

CDE Issues Draft Pharmaceutical Guidance for Rare Disea... CDE Issues Technical Guideline for Generic Sodium Iodid... CDE Issues Technical Guideline for Clinical Trials of C... CDE Issues Trial Guideline for Neuropathic Pain Drug De... 2026 National Conference on Drug Registration and Post-...

NHSA Issues Trial Measures for Early Communication on R... China Issues Revised Rules for National Essential Drug ... China Moves to Accelerate New Healthcare Insurance Mode... China Launches Nationwide Crackdown on BMI Fraud in Men... China's Health Insurance Market Poised for $596B Surge ...

Pentagon Reverses Decision After Briefly Listing WuXi A... China Indicts AstraZeneca and Former China Head Leon Wa... Roche and Henlius–Organon Resolve U.S. Patent Dispute ... China Warns of Foreign Misuse of Research Ties to Acces... China's Supreme Court Upholds Semaglutide Patent, Stren...

Hybio Wins CNY 180M GLP-1 API Order as Novo Nordisk See... Abraham Accords Partners Could Help the U.S. Reduce Pha... PhIIC Report Highlights China's API Industry Rebound as... India and China Explore Reverse-Trade Model for Pharmac... Clariant Completes Expansion of Pharma Excipients and S...

Lilly China's Mounjaro Approved for Type 2 Diabetes Mon... Lilly's Jaypirca Approved in China for Previously Treat... RemeGen Advances PD-1/VEGF BsAb RC148 Into Phase 3 Tria... Ascletis Picks Oral Amylin Agonist ASC36 for Obesity De... GSK's RSV Vaccine Arexvy Moves Forward in China

BioAtla and BeiGene Revise Global Deal for Novel Condit... Pfizer to Absorb Mylan, Creating Global Generic Powerho... PhRMA Calls for Trade Deals That Force Countries to Pay... IQVIA: Global Pharma to Grow Slower in the Next Five Ye... Pfizer and GSK Announce JV to Create a Global Consumer ...

Recent Executive Moves Recent Official and Executive Moves Recent Executive Moves Recent Executive Moves Recent Executive Moves

China Introduces Plan for Pudong New Area's Pilot Compr... Upcoming Event: 2023 Pharma CI USA Conference & Exhibit... Upcoming Event: 15th Annual Pharma Market Research Conf... Upcoming Event: 6th International Conference on Emergin... Upcoming Event: PHARM Connect Congress

Pharma China is the most influential English media and source of business intelligence covering the Chinese pharmaceutical and biopharmaceutical sector...

WiCON has been helping international healthcare companies succeed in China and other Asian markets since 1991. We advise our clients on every stage of their China and Asian business. We worked with clients in many regions of the world...

2023 Order Form + Product Descripti... WiCON Publishes the China Pharmaceu... WiCON Publishes the China Pharmaceu... WiCON Publishes the China Pharmaceu... WiCON Publishes the China Pharmaceu...